Administering corticosteroids to deceased, heart-beating kidney donors at least three hours before organ harvesting to reduce inflammation does not reduce the incidence or duration of post-transplantation acute renal failure (ARF) in transplant recipients, according to a report in Annals of Internal Medicine (2010;153:222-230).
Among 306 such donors and 455 renal-transplant recipients, 22% of recipients of steroid-treated donors and 25% of recipients of placebo-treated donors experienced ARF (the need for more than one dialysis session in the first week post-transplantation).
The median duration of ARF was five days and four days in the steroid and placebo arms, respectively.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.